News

Seoul Viosys’ Violeds Technology proves 99 percent Disinfection of COVID Variant

Violeds Technology TCBU Edited

Seoul Viosys confirms COVID-19 Delta variant was disinfected in a second to support Airborne Viruses Prevention.

Seoul Viosys, one of the leading global compound semiconductor device providers and subsidiary of Seoul Semiconductor, announced it has confirmed that the highly infectious Covid-19 delta variant was disinfected by 99.3 percent in one second, according to a surface disinfection experiment using Violeds technology conducted by the Korea University research team in July 2021. In the air disinfection experiment using Violeds technology conducted in Seoul Viosys’ laboratory (60㎥), the virus was reduced by 90 percent in 10 minutes.

In a disinfection experiment conducted by a research team at Korea University last year, Seoul Viosys confirmed that Violeds disinfects 99.9 percent of the COVID-19 virus in 30 seconds. In addition, in the air disinfection experiment of Korea Testing Laboratory (KTL), the research result showed that Violeds disinfects a space of 60㎥ by 99 percent in 30 minutes.

Chung-hoon Lee, CEO of Seoul Semiconductor and founder of Seoul Viosys said,  “Violeds technology is innovative in that it can be easily installed in various multi-use facilities as well as in poorly ventilated underground spaces, and it can minimise the spread of viruses through the air. I hope that the government and home appliance companies will actively use this technology to prevent the spread of infection, and also that local governments will take an active role in alleviating the suffering of the self-employed as soon as possible.”

Violeds technology, which can be installed not only in air purifiers and air conditioners but also in ducts (air conditioning systems) of buildings, is expected to play a major role in creating a pleasant working environment for office spaces or public buildings.

For more info, visit: http://violeds.net/en/

Cookie Consent

We use cookies to personalize your experience. By continuing to visit this website you agree to our Terms & Conditions, Privacy Policy and Cookie Policy.

Click to comment

You must be logged in to post a comment Login

Leave a Reply

RECENT POST

To Top